Gileadi U - Search Results

1

Non-glycosidic compounds can stimulate both human and mouse iNKT cells.

Jukes JP, Gileadi U, Ghadbane H, Yu TF, Shepherd D, Cox LR, Besra GS, Cerundolo V. Jukes JP, et al. Among authors: gileadi u. Eur J Immunol. 2016 May;46(5):1224-34. doi: 10.1002/eji.201546114. Epub 2016 Mar 1. Eur J Immunol. 2016. PMID: 26873393 Free PMC article.

2

IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.

Sewell AK, Price DA, Teisserenc H, Booth BL Jr, Gileadi U, Flavin FM, Trowsdale J, Phillips RE, Cerundolo V. Sewell AK, et al. Among authors: gileadi u. J Immunol. 1999 Jun 15;162(12):7075-9. J Immunol. 1999. PMID: 10358150

3

Effect of epitope flanking residues on the presentation of N-terminal cytotoxic T lymphocyte epitopes.

Gileadi U, Gallimore A, Van der Bruggen P, Cerundolo V. Gileadi U, et al. Eur J Immunol. 1999 Jul;29(7):2213-22. doi: 10.1002/(SICI)1521-4141(199907)29:07<2213::AID-IMMU2213>3.0.CO;2-8. Eur J Immunol. 1999. PMID: 10427984 Free article.

4

Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.

Gileadi U, Moins-Teisserenc HT, Correa I, Booth BL Jr, Dunbar PR, Sewell AK, Trowsdale J, Phillips RE, Cerundolo V. Gileadi U, et al. J Immunol. 1999 Dec 1;163(11):6045-52. J Immunol. 1999. PMID: 10570292

5

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.

Chen JL, Dunbar PR, Gileadi U, Jäger E, Gnjatic S, Nagata Y, Stockert E, Panicali DL, Chen YT, Knuth A, Old LJ, Cerundolo V. Chen JL, et al. Among authors: gileadi u. J Immunol. 2000 Jul 15;165(2):948-55. doi: 10.4049/jimmunol.165.2.948. J Immunol. 2000. PMID: 10878370

6

Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.

Evans M, Borysiewicz LK, Evans AS, Rowe M, Jones M, Gileadi U, Cerundolo V, Man S. Evans M, et al. Among authors: gileadi u. J Immunol. 2001 Nov 1;167(9):5420-8. doi: 10.4049/jimmunol.167.9.5420. J Immunol. 2001. PMID: 11673561

7

Competition between CTL narrows the immune response induced by prime-boost vaccination protocols.

Palmowski MJ, Choi EM, Hermans IF, Gilbert SC, Chen JL, Gileadi U, Salio M, Van Pel A, Man S, Bonin E, Liljestrom P, Dunbar PR, Cerundolo V. Palmowski MJ, et al. Among authors: gileadi u. J Immunol. 2002 May 1;168(9):4391-8. doi: 10.4049/jimmunol.168.9.4391. J Immunol. 2002. PMID: 11970981

8

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.

Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, Schmidt R, Harris AL, Old L, Cerundolo V. Hermans IF, et al. Among authors: gileadi u. J Immunol. 2003 Nov 15;171(10):5140-7. doi: 10.4049/jimmunol.171.10.5140. J Immunol. 2003. PMID: 14607913

9

The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.

Hermans IF, Silk JD, Yang J, Palmowski MJ, Gileadi U, McCarthy C, Salio M, Ronchese F, Cerundolo V. Hermans IF, et al. Among authors: gileadi u. J Immunol Methods. 2004 Feb 1;285(1):25-40. doi: 10.1016/j.jim.2003.10.017. J Immunol Methods. 2004. PMID: 14871532

10

Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy.

Silk JD, Hermans IF, Gileadi U, Chong TW, Shepherd D, Salio M, Mathew B, Schmidt RR, Lunt SJ, Williams KJ, Stratford IJ, Harris AL, Cerundolo V. Silk JD, et al. Among authors: gileadi u. J Clin Invest. 2004 Dec;114(12):1800-11. doi: 10.1172/JCI22046. J Clin Invest. 2004. PMID: 15599405 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters